Multiply Labs

Today, we're excited to share 𝗕𝗥𝗔𝗖𝗘: a whole-body controller that lets a humanoid exert or compensate against external loads on diverse terrains while tracking human motion in real-time. This was first authored by our Research Intern @sudarshan_s_h!

I’m very happy to announce that @multiplylabs 𝗵𝗮𝘀 𝗿𝗮𝗶𝘀𝗲𝗱 𝗮 $𝟳𝟱𝗠 𝗦𝗲𝗿𝗶𝗲𝘀 𝗕, led by @NantWorks, with the participation of new investors @AstraZeneca, Lingotto, Ora Global, @Teradyneinc , and Strange Ventures. Thank you also to our returning investors, including @fiftyyears, @cascapital, @Lux_Capital, and @foundersfund. Tens of billions of dollars are flowing into AI drug discovery, and AI is now designing more drug candidates (including personalized therapies!) than the industry will ever be able to manufacture with old-fashioned manual processes. It’s crazy that some of the most advanced medicines on the planet are still made largely by hand! I don’t think it’s acceptable that, while the science works so well, it’s still not possible to make enough therapies at an affordable price. The Multiply Labs team and I believe that 𝗿𝗼𝗯𝗼𝘁𝗶𝗰𝘀 𝗶𝘀 𝘁𝗵𝗲 𝗼𝗻𝗹𝘆 𝘄𝗮𝘆 to enable the next generation of biological medicines to reach truly industrial scale. This round enables us to turn this future into reality, by scaling our supply chain and the automated learning capabilities of our robots. A warm welcome to @IleanaPirozzi, who joins our Board. And the biggest thank you to the @multiplylabs team, who build & train these robots every single day! We are super excited to keep building, and we will have a lot more to show you very soon! Coverage in the thread below!

It was a pleasure to sit down with @adrianmacneil and the @foxglove team to show how @multiplylabs uses Foxglove as we build physical AI for biomanufacturing! The next generation of biological therapies are being rapidly discovered and approved for patient use. The bottleneck is manufacturing. We believe that a 𝗳𝘂𝗹𝗹𝘆 𝗿𝗼𝗯𝗼𝘁𝗶𝗰 𝗳𝗮𝗰𝘁𝗼𝗿𝘆 is the only way to manufacture biological therapies of all types at scale. One lesson keeps proving itself: 𝘀𝗰𝗮𝗹𝗶𝗻𝗴 𝗿𝗼𝗯𝗼𝘁𝘀 𝗶𝘀 𝗮 𝗱𝗮𝘁𝗮 𝗽𝗿𝗼𝗯𝗹𝗲𝗺. Instead of manually stitching together logs, our team streams every robotic event to the cloud through the Foxglove Agent and understands system behavior from one place. Full case study in the replies!

1/7) @NVIDIA is powering a massive wave of AI across life sciences - from drug discovery to digital biology. Models are improving rapidly. The pace of innovation is only accelerating!

Which one is 𝗿𝗲𝗮𝗹, and which one is 𝘀𝗶𝗺!? More importantly, 𝙬𝙝𝙮 𝙖𝙧𝙚 𝙬𝙚 𝙙𝙤𝙞𝙣𝙜 𝙩𝙝𝙞𝙨? 𝗧𝗵𝗲 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗧𝘄𝗶𝗻: Together with @nvidia, we’re using Isaac Sim to build 𝗵𝗶𝗴𝗵-𝗳𝗶𝗱𝗲𝗹𝗶𝘁𝘆 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝘁𝘄𝗶𝗻𝘀 of our robotic clusters so our engineers can: - 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗲 sequences and safety logic 𝘣𝘦𝘧𝘰𝘳𝘦 𝘵𝘩𝘦𝘺 𝘵𝘰𝘶𝘤𝘩 𝘩𝘢𝘳𝘥𝘸𝘢𝘳𝘦. - Develop features 𝗳𝗮𝘀𝘁𝗲𝗿, stress-testing edge cases we’d 𝘯𝘦𝘷𝘦𝘳 𝘳𝘶𝘯 𝘰𝘯 𝘢 𝘭𝘪𝘷𝘦 𝘴𝘺𝘴𝘵𝘦𝘮. - 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗮𝗰𝗰𝗲𝘀𝘀 so any engineer can test 𝘸𝘪𝘵𝘩𝘰𝘶𝘵 𝘣𝘰𝘰𝘬𝘪𝘯𝘨 𝘴𝘤𝘢𝘳𝘤𝘦 𝘤𝘭𝘶𝘴𝘵𝘦𝘳 𝘵𝘪𝘮𝘦. 𝗧𝗵𝗲 𝗪𝗵𝘆: In cell therapy manufacturing, 𝙚𝙫𝙚𝙧𝙮 𝙢𝙞𝙣𝙪𝙩𝙚 𝙤𝙣 𝙖 𝙥𝙧𝙤𝙙𝙪𝙘𝙩𝙞𝙤𝙣 𝙘𝙡𝙪𝙨𝙩𝙚𝙧 𝙞𝙨 𝙥𝙧𝙚𝙘𝙞𝙤𝙪𝙨. Our goal at @multiplylabs is simple: keep our production systems focused on 𝘮𝘢𝘬𝘪𝘯𝘨 𝘵𝘩𝘦𝘳𝘢𝘱𝘪𝘦𝘴 𝘧𝘰𝘳 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴, while we iterate and validate processes 𝘀𝗮𝗳𝗲𝗹𝘆 𝗶𝗻 𝘀𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻! Huge thanks to our collaborators @nvidia Healthcare and support from @NVIDIARobotics, as well as the Isaac Sim Team for empowering us with their next-generation software-in-the-loop simulation technology! Our mission is to build the 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗯𝗲𝘀𝘁 𝗿𝗼𝗯𝗼𝘁𝘀 and use them to make 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝘄𝗶𝗱𝗲𝗹𝘆 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲. If you love cutting edge robotics, or love the use of robotics for good, please leave a comment below - we’re always looking for talented builders! #robotics #biomanufacturing #simulation #digitaltwin #celltherapy #nvidia

The year is 2025 - our interns use VR headsets to teleoperate humanoid robots for pharma manufacturing, where sterility is essential for life-saving therapies. Give ambitious people projects at the edge of possibility, and they do extraordinary things! #Robotics #VR #Pharma

As we scaled the throughput of our robotic systems at @multiplylabs, we realized that wherever there are humans performing repetitive tasks, that always eventually becomes the bottleneck. Watch our engineering journey below in our first ever "Lab Notes" style video!